Find clinical trials for Triple Negative Breast Cancer in St Louis, MO
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near St Louis, MO, USA:
immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.This study will ...
Phase 2
Swansea, Illinois, United States and 5 other locations
of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...
Phase 1, Phase 2
St Louis, Missouri, United States and 31 other locations
(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...
Phase 1, Phase 2
St Louis, Missouri, United States and 15 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Swansea, Illinois, United States and 216 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
O'Fallon, Illinois, United States and 294 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
St Louis, Missouri, United States and 372 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
St Louis, Missouri, United States and 275 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
St Louis, Missouri, United States and 315 other locations
A study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of ABBV-927 with ABBV-368, Budigalimab (ABBV-181) an...
Phase 1
St Louis, Missouri, United States and 28 other locations
of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors with CCNE1 amplification). Main qu...
Phase 1
St Louis, Missouri, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal